Web Analysis for Bmsfrance - bmsfrance.fr
Découvrez Bristol-Myers Squibb et sa mission visant à découvrir, développer et fournir des médicaments innovants qui aident les patients à vaincre des maladies graves.
bmsfrance.fr is 1 decade 9 years old. It is a domain having fr extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, bmsfrance.fr is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | 59 |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | 27,800 |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | No Risk Issues |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | 2 | H2 Headings: | 5 |
H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
H5 Headings: | 5 | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | 15 |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 198.155.184.133)
Bristol-Myers Squibb - 跨国生物制药公司
深入了解Bristol-Myers Squibb以及我们的使命——探索、研发创新性药物,并将它交给患有重大疾病的患者。
BMS HEALTHCARE:医療関係者向け情報サイト
「BMS HEALTHCARE」はブリストル・マイヤーズ スクイブ株式会社が提供する医療関係者向け情報サイトです。
ORENCIA® (abatacept) | Official Patient Site
ORENCIA® (abatacept) is a prescription medication for moderate to severe Adult Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Adult Psoriatic Arthritis. Please see Indication and Important Safety Information.
YERVOY®(ipilimumab) | Consumer | Gateway
YERVOY is a prescription medicine used in adults and children 12 years of age and older to treat melanoma. See Indication, Important Safety Information, and Boxed Warning.
Bristol-Myers Squibb - Global Biopharmaceutical Company
Learn more about Bristol-Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.
HTTP Header Analysis
Content-Type: text/html;charset=utf-8
Content-Length: 65210
Connection: close
Date: Wed, 11 Dec 2019 11:08:39 GMT
Server: Apache
X-Content-Type-Options: nosniff
Last-Modified: Tue, 10 Dec 2019 16:22:49 GMT
ETag: "feba-5995bec5419ee"
Accept-Ranges: bytes
X-Dispatcher: dispatcher2useast1
X-Dispatcher-Number: 2
X-Vhost: publish
X-Frame-Options: SAMEORIGIN
Cache-Control: max-age=900,s-maxage=1800
Vary: Host,Accept-Encoding,User-Agent
X-Cache: Miss from cloudfront
Via: 1.1 a49beccddd651bd6995de9c2682b9a94.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: SFO5-C1
X-Amz-Cf-Id: yQiCzNTCXymFBXKaXI8iNpQAXe3krOoIElLtJgRzA_dBbGkCIDYo9A==
Domain Nameserver Information
Host | IP Address | Country | |
---|---|---|---|
ns1.bms.com | 198.155.167.250 | United States of America | |
ns2.bms.com | 198.155.167.248 | United States of America | |
ns3.bms.com | 198.155.223.8 | Germany |
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
bmsfrance.fr | A | 299 |
IP: 198.155.184.133 |
bmsfrance.fr | NS | 300 |
Target: ns1.bms.com |
bmsfrance.fr | NS | 300 |
Target: ns2.bms.com |
bmsfrance.fr | NS | 300 |
Target: ns3.bms.com |
bmsfrance.fr | NS | 300 |
Target: ns4.bms.com |
bmsfrance.fr | SOA | 300 |
MNAME: ns.bms.com RNAME: dnsadmin.bms.com Serial: 2010102447 Refresh: 3600 Retry: 600 Expire: 604800 Minimum TTL: 3600 |
bmsfrance.fr | MX | 300 |
Priority: 10 Target: mx.dnsassurance.com |
Full WHOIS Lookup
%% This is the AFNIC Whois server.
%%
%% complete date format : YYYY-MM-DDThh:mm:ssZ
%% short date format : DD/MM
%% version : FRNIC-2.5
%%
%% Rights restricted by copyright.
%% See https://www.afnic.fr/en/products-and-services/services/whois/whois-special-notice/
%%
%% Use '-h' option to obtain more information about this service.
%%
%% [103.111.79.131 REQUEST] >> bmsfrance.fr
%%
%% RL Net [##########] - RL IP [#########.]
%%
domain: bmsfrance.fr
status: ACTIVE
hold: NO
holder-c: BMS339-FRNIC
admin-c: GF6388-FRNIC
tech-c: DA6025-FRNIC
zone-c: NFC1-FRNIC
nsl-id: NSL21281-FRNIC
registrar: CSC CORPORATE DOMAINS INC.
Expiry Date: 2020-12-07T08:31:01Z
created: 2004-12-07T08:31:01Z
last-update: 2019-12-03T06:18:36Z
source: FRNIC
ns-list: NSL21281-FRNIC
nserver: ns1.bms.com
nserver: ns2.bms.com
nserver: ns3.bms.com
source: FRNIC
registrar: CSC CORPORATE DOMAINS INC.
type: Isp Option 1
address: 251 Little Falls Drive
address: DE 19808 WILMINGTON
country: US
phone: +1 302 636 5400
fax-no: +1 302 636 5454
e-mail: tldsupport@cscglobal.com
website: https://www.cscdigitalbrand.services
anonymous: NO
registered: 2006-10-17T12:00:00Z
source: FRNIC
nic-hdl: BMS339-FRNIC
type: ORGANIZATION
contact: Bristol-Myers Squibb
address: la Grande Arche Nord
address: 92044 Paris la Defense Cedex
country: FR
phone: +33 1 40 90 61 86
e-mail: dns.admin@bms.com
registrar: CSC CORPORATE DOMAINS INC.
changed: 2015-03-24T13:06:48Z nic@nic.fr
anonymous: NO
obsoleted: NO
eligstatus: ok
eligsource: REGISTRY
eligdate: 2018-11-13T23:00:00Z
reachmedia: email
reachstatus: ok
reachsource: REGISTRY
reachdate: 2018-11-13T23:00:00Z
source: FRNIC
nic-hdl: GF6388-FRNIC
type: PERSON
contact: Guillaume Famechon
address: Bristol Myers Squibb
address: la Grande Arche Nord
address: 92044 Paris la Defense Cedex
country: FR
phone: +33 1 40 90 61 86
e-mail: dns.admin@bms.com
registrar: CSC CORPORATE DOMAINS INC.
changed: 2015-03-24T12:30:29Z nic@nic.fr
anonymous: NO
obsoleted: NO
eligstatus: not identified
reachstatus: not identified
source: FRNIC
nic-hdl: DA6025-FRNIC
type: PERSON
contact: Dns Administrator
address: CSC Corporate Domains, Inc.
address: 251 Little Falls Drive
address: 19808 Wilmington
address: DE
country: US
phone: +1 3026365400
fax-no: +1 3026365454
e-mail: dns-admin@cscglobal.com
registrar: CSC CORPORATE DOMAINS INC.
changed: 2018-10-04T13:58:09Z nic@nic.fr
anonymous: NO
obsoleted: NO
eligstatus: ok
eligsource: REGISTRAR
eligdate: 2018-10-04T13:58:09Z
reachmedia: email
reachstatus: ok
reachsource: REGISTRAR
reachdate: 2018-10-04T13:58:09Z
source: FRNIC